<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="rss2full.xsl" type="text/xsl" media="screen"?><?xml-stylesheet href="itemcontent.css" type="text/css" media="screen"?><rss xmlns:blogChannel="http://backend.userland.com/blogChannelModule" xmlns:source="http://purl.org/my/rss/module/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
    <channel>
        <title>Mass High Tech Newspaper | Mass High Tech: The Journal of New England Technology</title>
            <link>http://www.masshightech.com/latestnews.html</link>
            <description>Mass High Tech: The Journal of New England Technology : breaking news from Mass High Tech</description>
            <pubDate>Tue, 09 Feb 2010 17:41:06 -0500</pubDate>
            <language>en-US</language>
            <image>
                <link>http://www.masshightech.com/</link>
                <url>http://www.masshightech.com/images/flag.gif</url>
                <title>Mass High Tech: The Journal of New England Technology</title>
            </image>
<item>
<title>Gilbane Group acquired by research firm Outsell</title>
<link>http://www.masshightech.com/stories/2010/02/08/daily25-Gilbane-Group-acquired-by-research-firm-Outsell.html</link>
<pubDate>Tue, 09 Feb 2010 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Journal of New England Technology</source:pub>
<description>The Gilbane Group, a Cambridge-based information technology analysis and consulting firm, has been acquired by California and London research and advisory firm Outsell Inc.</description>
</item>
<item>
<title>MS experts join Biogen Idec R&amp;D team</title>
<link>http://www.masshightech.com/stories/2010/02/08/daily24-MS-experts-join-Biogen-Idec-RD-team.html</link>
<pubDate>Tue, 09 Feb 2010 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Journal of New England Technology</source:pub>
<description>Cambridge biotechnology firm Biogen Idec Inc. has added multiple sclerosis experts John Richert and Nancy Richert to its research and development team. </description>
</item>
<item>
<title>Charles River revenue hit by downturn</title>
<link>http://www.masshightech.com/stories/2010/02/08/daily23-Charles-River-revenue-hit-by-downturn.html</link>
<pubDate>Tue, 09 Feb 2010 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Journal of New England Technology</source:pub>
<description>Wilmington-based contract research organization Charles River Laboratories reported that sales dropped 5 percent for the fourth quarter of 2009, compared to the year-ago period. Revenue for the year was down slightly. </description>
</item>
<item>
<title>Nyer Medical delisting paves way for dissolution</title>
<link>http://www.masshightech.com/stories/2010/02/08/daily22-Nyer-Medical-delisting-paves-way-for-dissolution.html</link>
<pubDate>Tue, 09 Feb 2010 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Journal of New England Technology</source:pub>
<description>Nyer Medical Group Inc., a Holliston-based holding company with medical supplies businesses, has announced plans to voluntarily de-list its securities from the Nasdaq Stock Market and to move forward with dissolving the company. </description>
</item>
<item>
<title>Cosmetic laser firm Cynosure plans cost cuts amid sales drop</title>
<link>http://www.masshightech.com/stories/2010/02/08/daily21-Cosmetic-laser-firm-Cynosure-plans-cost-cuts-amid-sales-drop.html</link>
<pubDate>Tue, 09 Feb 2010 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Journal of New England Technology</source:pub>
<description>Cynosure Inc., a developer of lasers used for cosmetic procedures and dermatology-related applications, said a rebound from its year-long sales slump is still a ways off, and it plans to cut its annual operating expenses by up to 12 percent to weather the storm. </description>
</item>
<item>
<title>Biogen's MS drug drives profits up in 2009</title>
<link>http://www.masshightech.com/stories/2010/02/08/daily20-Biogens-MS-drug-drives-profits-up-in-2009.html</link>
<pubDate>Tue, 09 Feb 2010 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Journal of New England Technology</source:pub>
<description>Biogen Idec is reporting that the company’s profits were up 24 percent for 2009, driven by revenue from its multiple sclerosis therapy, Tysabri.</description>
</item>
<item>
<title>Nuance sees first quarter revenue gain</title>
<link>http://www.masshightech.com/stories/2010/02/08/daily19-Nuance-sees-first-quarter-revenue-gain.html</link>
<pubDate>Tue, 09 Feb 2010 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Journal of New England Technology</source:pub>
<description>Shares in Burlington speech-to-text software maker Nuance Communications Inc. began the day up more than 50 cents a share this morning, before settling down, after the company announced improved earnings and a step back toward profitability in its Q1 2010, which ended Dec. 31. </description>
</item>
<item>
<title>Startup Watch: Five you should follow</title>
<link>http://www.masshightech.com/stories/2010/02/08/daily18-Startup-Watch-Five-you-should-follow.html</link>
<pubDate>Tue, 09 Feb 2010 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Journal of New England Technology</source:pub>
<description>As part of each week’s Startup Report, Mass High Tech highlights five startup companies, and their business goals, that are profiled in the New England Tech Directory. Included in this week’s Startup Report: Harvest Power, HeartWare International, Joule Biotechnologies, Plummelo and The Beer Genome.</description>
</item>
<item>
<title>Slater puts $500K into wound startup CytoSolv</title>
<link>http://www.masshightech.com/stories/2010/02/08/daily17-Slater-puts-500K-into-wound-startup-CytoSolv.html</link>
<pubDate>Tue, 09 Feb 2010 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Journal of New England Technology</source:pub>
<description>CytoSolv Inc., a biotech startup in Providence, R.I., has taken in $500,000 in seed-stage funding from the Slater Technology Fund, Rhode Island’s state-backed venture capital fund. </description>
</item>
<item>
<title>SiCortex co-founder Mucci dies of reported heart attack</title>
<link>http://www.masshightech.com/stories/2010/02/08/daily16-SiCortex-co-founder-Mucci-dies-of-reported-heart-attack.html</link>
<pubDate>Tue, 09 Feb 2010 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Journal of New England Technology</source:pub>
<description>John Mucci, co-founder of the recently closed high-performance computing company SiCortex Inc. of Maynard, died yesterday of an apparent heart attack, according to colleagues and news reports. </description>
</item>
</channel>
</rss>
